How Should the FDA Evaluate Psychedelic Medicine?
New England Journal of Medicine November 4, 2023 DOI: 10.1056/nejmp2308940 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Drug approval Alternative medicine Clinical research Pharmacology Pathology |
| Citations | 11 |
| Key findings | The FDA's draft guidance on psychedelics research includes recommendations that may be contentious. |
Abstract
Mounting clinical evidence could lead to the approval of new psychedelic medicines. The FDA’s draft guidance on psychedelics research includes several recommendations that may be contentious.